
T-cell Modulation Group
@tcellresearch
Professor Andrew Sewell's research group.
Pushing the boundaries of T-cell research
ID: 1202201261401165824
04-12-2019 12:21:37
78 Tweet
611 Followers
117 Following





John Haanen The Netherlands Cancer Institute Fundación BBVA Asociación Española Contra el Cáncer SOMM alliance Agencia Estatal de Investigación 📢 Discover new cancer targets through the analysis of successful cancer immunotherapy with Andrew Sewell T-cell Modulation Group, Cardiff University, at #VHIOBBVASymposium. Stay tuned for groundbreaking insights‼️




Don't miss the amazing Prof Andy Sewell (T-cell Modulation Group) from Cardiff University discussing his work on killer T cells in cancer survivors! Have you registered yet? Earlybird closes Wednesday, get involved!🚨 Register👉 bit.ly/3QP9E9n BSI Congress & Events #TumourMicroenvironment24


Thanks to the team for seeing our latest type 1 diabetes study over the line and published! 🏁 With special thanks to Lucy Jones and colleagues for rounding up the patient samples - we can’t do our research without their the generous participation! 🙏🏻 jci.org/articles/view/…

Thanks to children, young people & adults who met me & took part in this study. Without volunteers we can't do research to learn more about health- Thank you for taking part 👏 Here's our findings👇 Cwm Taf Morgannwg Research & Development Cardiff University School of Medicine Systems Immunity Research Institute T-cell Modulation Group jci.org/articles/view/…


Great to see this published in Journal of Clinical Investigation -Our own Lucy Jones and Brad Spiller collaborating with T-cell Modulation Group done at Systems Immunity Research Institute show that #Klebsiella oxytoca-derived peptides may trigger autoimmunity & type I #diabetes after infection of those with HLA A*24:02





What do you know about CAIT cells? T-cell Modulation Group report a new T cell subset that responds to a common MR1-restricted ligand on the surface of cancer cells in Journal of Clinical Investigation 👇 jci.org/articles/view/… #Immunology #Research #CancerResearch




Team NexTGen reveals a new T-cell subtype that uses MR1 to target cancer cells without harming healthy cells. This could transform immunotherapy and cancer vaccines. Read more in Journal of Clinical Investigation: jci.org/articles/view/… Dung Nguyen The Mark Foundation for Cancer Research

Congratulations Dr Hannah Thomas 🥂🍾#nolongeraPhDstudent 🥳 Thank you to her examiners for their time and patience too Ian Humphreys PaulKlenermanLab Awen Gallimore 🙏🏻
